EP2-Targeting Antibody (Abilita Bio)

N/A

Report date: 2025/01/26 16:14:25

Base Information

Drug NameEP2-Targeting Antibody (Abilita Bio)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionProstanoid EP2 receptor antagonists
TargetsProstanoid EP2 receptor
Therapy Area/IndicationsMetastatic breast cancer
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAbilita Bio Inc
China Registration ClassN/A

Develop Information

Active CompaniesAbilita Bio Inc
Inactive CompaniesN/A
Active IndicationsMetastatic breast cancer
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A